{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33761203",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "NEJMc2100362",
      "10.1056/NEJMc2100362"
    ],
    "Journal": {
      "ISSN": "1533-4406",
      "JournalIssue": {
        "Volume": "384",
        "Issue": "19",
        "PubDate": {
          "Year": "2021",
          "Month": "May",
          "Day": "13"
        }
      },
      "Title": "The New England journal of medicine",
      "ISOAbbreviation": "N Engl J Med"
    },
    "ArticleTitle": "New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.",
    "Pagination": {
      "StartPage": "1866",
      "EndPage": "1868",
      "MedlinePgn": "1866-1868"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for the AIDS Program of Research in South Africa, Durban, South Africa salim.abdoolkarim@caprisa.org."
          }
        ],
        "LastName": "Abdool Karim",
        "ForeName": "Salim S",
        "Initials": "SS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Durban, South Africa."
          }
        ],
        "LastName": "de Oliveira",
        "ForeName": "Tulio",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "N Engl J Med",
    "NlmUniqueID": "0255562",
    "ISSNLinking": "0028-4793"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [
        "epidemiology",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunogenicity, Vaccine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "South Africa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United Kingdom"
    }
  ]
}